Vyaire Medical today announced its support of a study to measure the short- and long-term impacts of COVID-19 pneumonia.
At Vyaire Medical, product development and innovation are dependent on the skillful teams that leverage science, technology, engineering and math (STEM) to do their jobs each day. STEM is critical to the work we do to enhance the quality of breathing through every stage of life.
Vyaire Medical chief executive officer Gaurav Agarwal was recently interviewed by McKinsey about the Vyaire Medical team’s dedicated efforts to ramp up production and meet patient needs in response to COVID-19.
Vyaire Medical, the world’s largest healthcare company fully dedicated to respiratory care, is using its global reach to quickly disseminate vital information for the care and treatment of patients suffering from COVID-19 worldwide.
Normally, joining a company to oversee more than half of its worldwide employees is a big challenge. Add a global pandemic to the mix and suddenly that task is amplified tremendously.
“I can’t breathe.”
Like so many of you, I’m nauseated when I see the images of George Floyd’s murder—to watch the humanity and life be stripped from him as he struggles to say those words. “I can’t breathe.”
Vyaire Medical associates throughout the company are taking on additional responsibilities in response to the global COVID-19 crisis in order to ensure patients are receiving the best treatment possible.
Product features are more than just bells and whistles. The various functions found on Vyaire Medical ventilators provide doctors, nurses and respiratory therapists with the critical tools they need to provide the best care to their patients.
Vyaire Medical employees have been doing whatever they can to meet the unprecedented demand for respiratory equipment for treating COVID-19 patients, not only expanding efforts in their normal roles, but also pitching in to help other departments. They’re also there to help one another.